Pfizer and Moderna are testing vaccines on children aged 12 and older and hope to have results by the summer, the New York Times reports.
The companies could then test the vaccines in younger children, depending on findings in the older cohort.
Johnson & Johnson, Novavax and AstraZeneca are in the process of putting similar plans into operation but are not quite at such an advanced stage.
